Advertisements

Althaeae sirupus

Quick links to important sections

Althaeae sirupus

Selected form

Advertisements
Advertisements

Method of action: Expectorant

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Althaeae sirupus

Property Description
Active ingredient Althaeae Officinalis Herbae Extract
Form Syrup (Liquid dosage form)
Pharmacological class Demulcent / Expectorant mean of herbal origin
General purpose Provides symptomatic relief of local irritation
Origin Herbal origin (Traditional Herbal Medicinal Product)

Althaeae sirupus: Definition and Herbal Origin

Althaeae sirupus, commonly known as marshmallow syrup, is officially classified as a Traditional Herbal Medicinal Product (THMP) and a phytopharmaceutical, rooted entirely in natural plant sources. It is a single active ingredient product derived from the plant's root, designated as Althaeae Officinalis Herbae Extract, which confirms its identity as a medicine of herbal origin. The marshmallow root has demulcent properties due to its high mucilage content. This understanding grounds the traditional application of the medicine as a means of physically protecting irritated tissues. This preparation falls primarily into the demulcent pharmacological class, recognized for its ability to soothe mucous membranes, with an associated action as an expectorant mean of herbal origin.


Composition, Form, and Active Constituent (Mucilage)

The preparation is formulated as a syrup, a palatable liquid dosage form intended for oral use, composed of the concentrated marshmallow extract dissolved in a syrup base. The key to the syrup's action is its active ingredient, the Althaeae Officinalis Herbae Extract, which is notably rich in mucilage, a type of soluble, high-molecular-weight polysaccharide. The high mucilage content is identified as the source of the protective action. This shows that the syrup's effect is due to the physical properties of the plant compounds. The concentration of these polysaccharides is essential, particularly for the target patient group of children and adolescents, as it provides the physical substance necessary for the medicine's defining demulcent effect upon administration.


General Purpose of the Demulcent Action

The fundamental general purpose of Althaeae sirupus is to achieve symptomatic relief via a purely physical, local demulcent action. This effect is initiated when the viscous mucilage creates a cohesive protective film that gently coats the irritated mucous membranes of the pharynx and upper alimentary tract. By forming this physical barrier, the syrup shields the underlying sensitive tissues and nerve endings from direct exposure to environmental or inflammatory irritants. Consequently, this local shielding action provides soothing relief and helps to reduce the sensation of dryness-related discomfort, a typical use scenario when managing throat irritation.

Advertisements

What side effects are possible with Althaeae sirupus?

Possible Side Effects and Safety Information

Official regulatory assessments classify the frequency of side effects associated with Althaeae sirupus as Not Known. This classification is due to a lack of sufficient clinical trial data to establish a precise frequency for any adverse reactions, although the product is classified for traditional use based on long-standing safety.

Safety Considerations and Restrictions

Serious Adverse Reactions: No specific serious adverse reactions are documented as directly linked to the use of Althaeae sirupus in the regulatory summaries.

Key Safety Restriction (Drug Interaction):

The most important safety-related limitation involves the potential for drug-drug interaction. Due to the high mucilage content of marshmallow root, the syrup may decrease or delay the absorption of other orally administered medicines. To prevent this, the product must be taken at least one hour after any other oral medication.

Population-Specific Safety:

  • Pregnancy and Breast-feeding: Reliable information regarding safety during pregnancy and lactation is insufficient. Use in these populations is generally advised to be avoided unless under the guidance of a qualified healthcare practitioner.
  • Children and Adolescents: Medicines containing ethanol extracts of marshmallow root are generally recommended only for adults due to a lack of adequate data for use in younger populations.

Regulatory Notes:

The EMA's Committee on Herbal Medicinal Products (HMPC) assessment categorizes the use of this herbal medicinal product as Traditional Use. Discontinuation of use and consultation with a healthcare professional are advised if symptoms persist longer than 1 week (for mouth/throat irritation) or 2 weeks (for mild stomach/gut discomfort).

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documentation states that the profile of acute overdose for Althaeae sirupus is not established because specific clinical manifestations have not been reported in regulatory literature. This finding means that the official prescribing information does not list specific symptoms, signs, or life-threatening outcomes following acute over-exposure to the herbal extract.

Since the active constituent is a high-molecular-weight polysaccharide with a physical, demulcent action, there is no specific antidote known for Althaeae Officinalis Herbae Extract. Therefore, in the rare event of suspected over-exposure, the required clinical management procedure is limited to symptomatic and supportive treatment, as mandated by regulatory standards for products lacking an antagonist. There are no specific requirements for hospital monitoring or observation defined in the overdose section.

Mandated guidance regarding when to seek medical help is primarily linked to the patient's condition during the course of treatment. Official regulatory labeling requires a healthcare professional to be consulted if symptoms of mouth or throat irritation do not improve after 1 week of using the product, or if adverse signs like dyspnoea, fever, or purulent sputum occur.

Advertisements

Therapeutic Uses of Althaeae sirupus

What Althaeae sirupus Treats: Main Uses and Benefits

The therapeutic utility of Althaeae sirupus is generally focused on providing supportive relief for symptoms related to physical discomfort in the upper airways.

Relieving Dry, Irritative Cough Patterns

This product is commonly used for the symptomatic treatment of oral or pharyngeal irritation and associated dry cough. It is relevant for easing symptoms that create noticeable physiological strain, particularly the irritative cough—a non-productive reflex driven by a persistent pharyngeal tickle. The syrup may assist in easing the impact of this disruptive cough reflex, which supports the patient during difficult episodes by easing distress.

“The primary benefit is symptomatic assistance for localized discomfort.”

Soothing Localized Mucosal Discomfort

The product is applied across domains where additional symptomatic support is needed to address symptom clusters that become more noticeable, such as scratchiness, dryness, and mild soreness in the throat. It is commonly used when groups of symptoms appear suddenly or fluctuate, offering symptomatic relief that helps patients cope more steadily with symptom fluctuations associated with acute or episodic changes. These indications make it relevant for use during acute symptomatic episodes of upper respiratory tract irritation and mild acute pharyngitis. It is commonly used within clinical settings that involve acute or unstable symptom patterns across patient groups, including adults and children.


Quick Fact: Relief for Irritative Symptoms Marshmallow syrup is commonly used to provide symptomatic relief for irritation of the throat and the resulting dry, reflex-driven cough.

Advertisements

Eligibility and Restrictions for Use

The official regulatory eligibility for Althaeae sirupus is defined by absolute contraindications and strict age-related limitations, primarily based on the European Medicines Agency (EMA) monograph for Marshmallow root (Althaea officinalis radix).

Populations Excluded from Use

Classification Population/Condition
Contraindicated Individuals with known hypersensitivity or allergy to the active substance or any excipients.
Contraindicated/Restricted Patients with Diabetes mellitus due to the high sucrose content of the syrup formulation.
Not Recommended Children under 3 years of age (requires medical advice prior to use).
Use Not Established Pregnancy and Lactation (safety has not been established due to lack of sufficient data).
Use Not Established Children under 12 years of age for the traditional use of relieving mild gastrointestinal discomfort.

Age-Related Eligibility

The syrup is generally authorized for adults, adolescents, and children 3 years of age and older for certain traditional uses, such as soothing irritation of the oral or pharyngeal mucosa. Use in the youngest pediatric group (under 3 years) is explicitly not recommended by regulatory bodies, indicating a clear boundary for non-eligibility due to safety concerns requiring medical assessment.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Althaeae sirupus (Marshmallow root syrup) is primarily defined by the physical effect of its high mucilage content, which is documented in official government regulatory information.

Pharmacokinetic Interactions (Absorption)

Marshmallow root may reduce or delay the absorption of concurrently administered oral medicinal products. This is not a chemical or metabolic interaction, but a physical one where the mucilage may form a protective layer that temporarily interferes with the uptake of other medicines in the gastrointestinal tract.

Specific detailed data on cytochrome P450 (CYP) enzyme or transporter-mediated interactions (such as P-gp or OATP) are generally not available in official regulatory labeling for this product.

Interaction Constraints and Separation Rules

To mitigate the risk of reduced or delayed absorption, specific time-based separation rules are required when combining Althaeae sirupus with other medicines.

Interacting Substance/Class Required Separation Time Regulatory Constraint
General Oral Medicinal Products 1/2 to 1 hour The product should not be taken 1/2 to 1 hour before or after other oral medicinal products.
Iron Salts 2 hours Intake of the syrup and Iron salts must be separated by two hours.

No specific pharmacodynamic interactions (additive effects) or contraindicated combinations are listed in the official regulatory documentation for this product.

Advertisements

Mechanism of Action

The mechanism of action for this syrup is predominantly non-systemic and physical, driven by the demulcent properties of its primary constituent, mucilage.

️ Physical Barrier Formation and Mucosal Shielding

The mechanism is initiated by the rapid hydration of the high-molecular-weight polysaccharides (mucilage) upon contact. This process forms a highly viscous, bioadhesive film that physically coats and adheres to the pharyngeal and oropharyngeal mucous membranes. This mechanism establishes a mechanical barrier that isolates the epithelial tissues and underlying sensory nerve endings from direct exposure to irritants, which is an upstream stage in the cascade leading to physiological modulation.

Peripheral Modulation of the Cough Reflex

By creating a physical shield over the mucosal surface, the syrup indirectly modulates the afferent limb of the cough reflex pathway. The mechanism affects the local sensory input by reducing the frequency and intensity of mechanical and chemical stimuli that interact with the pharyngeal sensory nerve endings. This reduction in peripheral input signal attenuates the reflex hyperexcitability, which represents the key physiological consequence resulting from this mechanism.

Local Epithelial Support and Cytokine Activity

Components of the extract demonstrate localized modulatory activity, including in vitro influence on the release of pro-inflammatory cytokines such as TNF-alpha and IL-6. This ancillary action modulates the local cytokine milieu, and other fractions influence epithelial cell vitality and proliferation, affecting the integrity of the mucosal barrier system.

Advertisements

Dosage and Administration Information

The administration of Althaeae sirupus follows protocols designed for the product’s liquid syrup formulation. The required route of administration is oral (perorally), where the liquid preparation provides a localized oromucosal coating action. Dosing schedules are defined by milliliter volumes and are differentiated by age group according to established standards.

The standard single dose for adults and adolescents is 10 ml to 15 ml of syrup, typically administered in a divided regimen 3 to 5 times daily, with a maximum daily intake of 50 ml. Pediatric dosing requires specific adjustment: children aged 6 to 11 years receive a single dose of 5 ml, 3 to 5 times daily, while children aged 3 to 5 years receive 5 ml up to 4 times daily. Use of the syrup is not recommended in children under 3 years of age.

A notable administration instruction is the time-separation requirement. The product should not be taken 1/2 to 1 hour before or after other oral medicines to avoid a physical interaction that may delay the absorption of concomitant drugs. If a dose is missed, a double dose must not be taken to compensate; the standard schedule should be resumed. The administration course is intended for short-term use, and professional consultation is advised if symptoms persist longer than one week.

Advertisements

Recent Clinical Evidence

Althaeae sirupus: Recent Clinical Evidence

Clinical evidence for the use of Althaeae sirupus (marshmallow root syrup) focuses primarily on its traditional application for the symptomatic relief of irritation of the oral or pharyngeal mucosa and associated dry cough.

Mechanism and Study Focus

The therapeutic action is generally attributed to the high content of mucilage (polysaccharides) found in the Althaea officinalis root. Research suggests this mucilage forms a protective, film-like layer over the irritated mucous membranes in the mouth and throat. This physical coating is believed to help soothe local irritation and limit the reflex that causes coughing.

Findings from Clinical Trials

The most comprehensive data comes from non-interventional studies (NIS) and consumer-reported outcome surveys, which document the use of marshmallow root extracts (often in syrup or lozenge form) in real-world settings. These studies have:

  • Assessed cough relief: They evaluated the impact on symptoms like throat irritation and dry cough, often reporting a perceived good effect by users.
  • Monitored onset of action: Consumer reports often suggest a rapid onset of effect, frequently within the first 10 minutes of use, which aligns with the proposed physical mechanism of mucosal coating.
  • Evaluated tolerability: The preparations are generally reported to have very good tolerability across adults, adolescents, and children over 3 years of age, with only minor, transient adverse events noted in surveys.

Other Research Areas

Preclinical and in vitro studies have also explored other properties of marshmallow root extracts, including anti-inflammatory and antioxidant activity, and a potential stimulating effect on epithelial cell vitality, which may relate to tissue regeneration. Additionally, a placebo-controlled trial has evaluated the use of the preparation in managing irritable cough induced by certain medications, reporting a statistically significant effect in the test group.

Marshmallow root preparations are also used traditionally to relieve mild discomfort of the stomach and gut, though clinical evidence in this specific area remains less extensive.

Key Studies & References

  1. [Marshmallow Root Extract for the Treatment of Irritative Cough: Two Surveys on Users' View on Effectiveness and Tolerability] - PubMed
  2. Phyto Antitussive Medicines Affect the Cough Treatment for Covid-19's Children's Patients (Includes mention of anti-inflammatory and demulcent mechanism)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Althaeae sirupus (FAQ)

Q: What is Althaeae sirupus used for?

Althaeae sirupus is traditionally used as an herbal medicine to relieve symptoms of irritation associated with a dry cough. Official product information indicates that it is traditionally described as helping to soothe the throat. This use is supported by its long-standing tradition in herbal medicine.

Q: Can children take Althaeae sirupus?

Regulatory documents state that Althaeae sirupus is suitable for use in children from the age of three years and older. Eligibility is based on age, and the official instructions specify different guidance for various age groups. Caregivers are advised to refer to the official product leaflet for detailed, age-appropriate information.

Q: How long can I use Althaeae sirupus?

According to the official product information, the duration of use is typically limited to a maximum of one week. If symptoms persist or worsen beyond seven days, a healthcare professional should be consulted. This recommended time frame is detailed in the regulatory guidance for the product.

Q: Is Althaeae sirupus safe to use during pregnancy and while breastfeeding?

Regulatory information indicates that Althaeae sirupus should not be used during pregnancy or while breastfeeding. This restriction is due to a lack of sufficient data on its safety during these periods. A healthcare provider can offer guidance on alternative treatment options.

Q: What should I do if I miss a dose?

If a dose of Althaeae sirupus is missed, the official guidance typically states that the next dose should be taken at the scheduled time. The guidance also specifies that users should not double the dose to make up for a missed one. Following the recommended schedule is part of the official instructions.

Q: Does Althaeae sirupus contain sugar?

Yes, regulatory documents confirm that Althaeae sirupus contains sugar, as indicated by the presence of sucrose. This is the main component of the syrup formulation. Individuals who are managing blood sugar levels or following a restricted diet should be aware of this component.

Advertisements

How should Althaeae sirupus be stored and disposed of?

Storage and Disposal Requirements for Althaeae sirupus

The official storage conditions for Althaeae sirupus are established to maintain the stability of the medicine.

Required Storage Conditions

Storage Component Official Requirement
Temperature Limit Must not be stored above 25 C.
Light Protection Store in the original package to protect from light.
Child Safety Must be kept out of the sight and reach of children.

Product Stability and Disposal

The regulatory labeling defines a storage life tied to the product's use. The medicine has an unopened shelf life of 3 years. After the bottle is opened for the first time, the remaining syrup must be discarded within 4 weeks. Regarding disposal, regulatory documentation states no special requirements for discarding the unused or expired product.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Althaeae sirupus found in:

A-Z Index: